Correction: Bednarek et al. Serum Osteoprotegerin Level Is Not a Localizing Biomarker of Atherosclerosis Affected by Kidney Function. Diagnostics 2026, 16, 786

Puntos clave

• To evaluate the effectiveness of serum osteoprotegerin as a biomarker for atherosclerosis in relation to kidney function.
• Review of original data on serum osteoprotegerin levels
• Analysis of the relationship between osteoprotegerin and atherosclerosis
• Comparison of results across varying kidney function statuses
• Confirmed that osteoprotegerin levels are not reliable indicators of atherosclerosis
• Indicated that kidney function does not influence osteoprotegerin's role as a biomarker